drugset / Trial / NCT02746237

Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585

NCT02746237 ↗

Phase 1 Completed 120 enrolled Karos Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

Safety, tolerability, pharmacokinetics (PK), cardiac conduction and food effect study on single and multiple ascending doses of KAR5585 in healthy adults.

Timeline

Start
2015-11
Primary completion
2016-05
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rodatristat Ethyl Small molecule 100 mg —